CU-Ludwig partnership
Charles Harrington/University Photography
From left, Frank Lee, manager of Cornell's new bioproduction facility, discusses the unit's
systems with Andy Simpson of the Ludwig Institute for Cancer Research; David Wilson, Cornell professor
of biochemistry; and Cornell President Hunter Rawlings at the facility's opening Nov. 13. It will
begin producing tumor antigens for Phase I clinical trials in about six months. Read the story.
|
 |
Highlights
New architectural firm chosen to design university's Milstein Hall
Poet Alice Fulton wins Bobbitt Prize for her book Felt
Initial phase of first workforce planning reviews is completed
Coups for Cornell: Physics and math stars are joining the faculty:
Seamus Davis
William Thurston
Grant helps biologists to study estrogen's role in breast cancer
CU workplace institute to study stress, trauma faced by NYC firefighters
CU Cinema presents acclaimed artists Shirin Neshat and Shoja Azari
Jazz Ensembles swing with Terell Stafford this weekend
|
